tomeko

Transgrediens et progrediens palmoplantar keratoderma

Just diagnosed with Transgrediens et progrediens palmoplantar keratoderma?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Transgrediens et progrediens palmoplantar keratoderma, look for clinical trials, and connect with others living with it — all in one place.

Open the full Transgrediens et progrediens palmoplantar keratoderma hub →

Overview

Transgrediens et progrediens palmoplantar keratoderma is a rare condition. Also known as Greither disease, Keratosis extremitatum hereditaria progrediens, Keratosis palmoplantaris transgrediens et progrediens, Progressive diffuse PPK, Progressive diffuse palmoplantar keratoderma, Transgrediens et progrediens PPK. Tomeko brings together the specialists, research, clinical trials, treatments and community for Transgrediens et progrediens palmoplantar keratoderma so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:495 · OMIM 133200 · ICD-10 Q82.8 · GARD 0003096

Find care for Transgrediens et progrediens palmoplantar keratoderma

Authoritative references for Transgrediens et progrediens palmoplantar keratoderma

Common questions

I was just diagnosed with Transgrediens et progrediens palmoplantar keratoderma — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Transgrediens et progrediens palmoplantar keratoderma, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Transgrediens et progrediens palmoplantar keratoderma?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Transgrediens et progrediens palmoplantar keratoderma, filtered to your area.

Are there clinical trials for Transgrediens et progrediens palmoplantar keratoderma?

Tomeko shows live, recruiting studies for Transgrediens et progrediens palmoplantar keratoderma from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com